Next, we analyzed scRNA-seq data from patients with EGFR-mutated lung cancer before EGFR-TKI treatment and after the development of drug resistance to confirm results seen in cell lines and compare gene expression levels in tumor and non-tumor cells (Fig. 1). This evidence concerns the gene EGFR and lung cancer.